Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,257.80
+11.10 (0.49%)
May 4, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 932.08 billion as of May 4, 2026. Its market cap has decreased by -3.76% in one year.
Market Cap
932.08B
Enterprise Value
983.21B
Revenue
139.14B
Ranking
n/a
PE Ratio
52.26
Stock Price
2,257.80
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 932.08B, an increase of 63.59%. That is a compound annual growth rate of 17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 927.50B | 2.29% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.73T |
| Cipla | 1.08T |
| Zydus Lifesciences | 897.46B |
| Aurobindo Pharma | 807.02B |
| Glenmark Pharmaceuticals | 679.06B |
| Alkem Laboratories | 645.65B |
| Laurus Labs | 594.36B |
| Ipca Laboratories | 388.40B |